| Sign In to gain access to subscriptions and/or personal tools. |
A Midterm Follow-Up Study of Bioreconstructive Polylactide Scaffold Implants in Metacarpophalangeal Joint Arthroplasty in Rheumatoid Arthritis Patients
From the Center of Rheumatic Diseases, Department of Internal Medicine and Department of Orthopaedics and Physiatrics, Tampere University Hospital, Tampere, Finland, and Medical School University of Tampere, Finland, Institute of Biomaterials, Tampere University of Technology, Tampere, Finland and Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland and Coxa, Hospital for Joint Replacement, Tampere, Finland
* To whom correspondence should be addressed.
This paper presents the results of a prospective study of 80 metacarpophalangeal joint arthroplasties, in which biodegradable polylactide 96/4 copolymer scaffolds were used. Twenty-three rheumatoid arthritis patients were assessed at an average of 59 months after operation, which exceeds the resorption time of P(L/D)LA 96/4 according to animal experiments. Palmar subluxation exceeded half of the bone thickness in 39 joints before operation and in nine at the last follow-up. Ulnar deviation decreased from 25° to 5°, extension deficit from 32° to 15° and active flexion from 76° to 63°. The results are comparable with published data on silicone implant arthroplasties. Implant resorption did not induce any significant osteolysis in the medium term and the restoration of the structure and function of the hand was maintained after implant resorption, probably as the guided fibrous tissues had replaced the dissolved implant. Key Words: metacarpophalangeal joint, rheumatoid arthritis, arthroplasty, implant, surgery
First published on March 12, 2009, doi:10.1177/1753193408099833 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||